TRCT
VOR icon

Tower Research Capital (TRC)’s Vor Biopharma VOR Stock Holding History

Tower Research Capital (TRC)’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1K Sell
1,741
-1,725
-50% -$26.1K ﹤0.01% 3119
2026
Q1 		$61.8K Buy
3,466
+1,737
+100% +$24.5K ﹤0.01% 2561
2025
Q4 		$22.6K Buy
1,729
+1,725
+43,125% +$32.1K ﹤0.01% 3012
2025
Q3 		$195 Sell
4
-111
-97% -$4.46K ﹤0.01% 5073
2025
Q2 		$3.72K Sell
115
-57
-33% -$504 ﹤0.01% 4442
2025
Q1 		$2.47K Sell
172
-8
-4% -$192 ﹤0.01% 4547
2024
Q4 		$4K Sell
180
-35
-16% -$580 ﹤0.01% 4542
2024
Q3 		$3.01K Sell
215
-566
-72% -$10.3K ﹤0.01% 4908
2024
Q2 		$15.6K Buy
781
+700
+864% +$22.6K ﹤0.01% 3900
2024
Q1 		$3.82K Sell
81
-185
-70% -$8.12K ﹤0.01% 4783
2023
Q4 		$12K Sell
266
-518
-66% -$21.4K ﹤0.01% 4088
2023
Q3 		$33.2K Buy
784
+679
+647% +$36.8K ﹤0.01% 2934
2023
Q2 		$6.49K Buy
+105
New +$9.59K ﹤0.01% 4698
2023
Q1 		– Sell
-1,294
Closed -$172K – 6315
2022
Q4 		$172K Sell
1,294
-1,039
-45% -$103K 0.01% 1408
2022
Q3 		$186K Buy
2,333
+1,257
+117% +$124K ﹤0.01% 2010
2022
Q2 		$107K Sell
1,076
-488
-31% -$49.9K ﹤0.01% 2234
2022
Q1 		$189K Buy
1,564
+641
+69% +$109K ﹤0.01% 1777
2021
Q4 		$215K Buy
923
+886
+2,395% +$255K ﹤0.01% 1714
2021
Q3 		$11K Sell
37
-10
-21% -$2.97K ﹤0.01% 4264
2021
Q2 		$17K Buy
47
+26
+124% +$12.8K ﹤0.01% 4055
2021
Q1 		$18K Buy
+21
New +$17.8K ﹤0.01% 3973

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $11.6B AUM 69.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tower Research Capital (TRC)'s VOR Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Vor Biopharma (VOR) stake by 50% in Q2 2026, selling an estimated $26.1K and leaving 1,741 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3119.

Tower Research Capital (TRC) first reported a position in VOR in Q1 2021 and has held it in 21 quarters since. The position peaked at $215K in Q4 2021. 43 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Tower Research Capital (TRC) held 1,741 shares of Vor Biopharma worth $32.1K as of Q2 2026.
  • Tower Research Capital (TRC) sold 1,725 Vor Biopharma shares in Q2 2026, an estimated $26.1K.
  • Vor Biopharma made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3119 holding.
  • Tower Research Capital (TRC) first reported a position in Vor Biopharma in Q1 2021 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Vor Biopharma position peaked at $215K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.